Comparison between Sify Infinit Spaces IPO and Yashoda Healthcare IPO.
Sify Infinit Spaces IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Yashoda Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Sify Infinit Spaces IPO is up to ₹3,700.00 Cr whereas the issue size of the Yashoda Healthcare IPO is up to ₹0.00 Cr. The final issue price of Sify Infinit Spaces IPO is and of Yashoda Healthcare IPO is .
| Sify Infinit Spaces IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹2,500.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,200.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹3,700.00 Cr | up to ₹0.00 Cr |
Sify Infinit Spaces IPO opens on , while Yashoda Healthcare IPO opens on . The closing date of Sify Infinit Spaces IPO and Yashoda Healthcare IPO is , and , respectively.
Sify Infinit Spaces IPO P/E ratio is , as compared to Yashoda Healthcare IPO P/E ratio of .
| Sify Infinit Spaces IPO | Yashoda Healthcare IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Sify Infinit Spaces Ltd.'s revenue increased by 27% and profit after tax (PAT) rose by 36% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials ()
| |||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.37 | ||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 7.68% | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Sify Infinit Spaces IPO Retail Individual Investors (RII) are offered 0 shares while in Yashoda Healthcare IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Sify Infinit Spaces IPO and in Yashoda Healthcare IPO.
| Sify Infinit Spaces IPO | Yashoda Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Sify Infinit Spaces IPO subscribed in total, whereas Yashoda Healthcare IPO subscribed .
